PPP: A push for affordable healthcare
04 February 2011 | News
In the second part of this series that decodes the success of PPPs and its prospects, BioSpectrum showcases three case studies that exemplify the benefits of such partnerships
Development of innovative technologies to facilitate research in 3D Cell Culture for Regenerative Medicine and Tissue Engineering by Hyderabad-based ExCel Matrix Biological Devices.Bhubneshwar-based Imgenex India's initiatives on developing drugs against osteoporosis using the applications of nanobiotechnology.New Delhi-based ARA Healthcare's projects to carry out pre-clinical and phase I clinical development of three recombinant proteins, ARA-I, ARA-II, and ARA-III.
Mission: Creating novel tissue engineering techniques
Mission: Tackling osteoporosis using nanobiotech
Mission: Fighting cancer with recombinant
